Self-reported Taste and Smell Disorders in Patients with COVID-19: Distinct Features in China
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
-
SciScore for 10.1101/2020.06.12.20128298: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: The study was approved by Tongji Hospital Research Ethics Committee. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources These statistical analyses were performed by using an IBM SPSS 22.0 package (SPSS Inc, Chicago, IL). SPSSsuggested: (SPSS, RRID:SCR_002865)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:In order to …
SciScore for 10.1101/2020.06.12.20128298: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: The study was approved by Tongji Hospital Research Ethics Committee. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources These statistical analyses were performed by using an IBM SPSS 22.0 package (SPSS Inc, Chicago, IL). SPSSsuggested: (SPSS, RRID:SCR_002865)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:In order to overcome this limitation in real-world setting, we did recalled questionnaires by phone call to reevaluate the presence of airway comorbidities, and frequency and severity of nasal symptoms. As a result, the frequencies of COVID-19 patients with AR and CRS were 9.8% and 6.1%, respectively. Previous studies have reported that adult AR and CRS in general population in China were 17.6% and 8%, respectively, these being higher than the reported for COVID-19 [24, 25]. Recent studies indicate that the increasing eosinophils may be an indicator of COVID-19 improvement [26, 27]. Hence, we cannot rule out the possibility that the comorbidities of allergic and eosinophilic diseases such as AR might be potential protective factors for severe COVID-19. Here, we found that upper respiratory tract symptoms were identified in 29.2% patients with COVID-19, with nasal obstruction, rhinorrhea, nasal itching and sneezing presenting in mild/moderate severity and loss of smell and taste presenting in moderate/severe severity. All of these upper respiratory tract symptoms have been commonly reported in other respiratory viral infection, such as influenza and rhinovirus [28-30]. Our data suggest that similar with the common respiratory virtues, SARS-CoV-2 may be able to infect upper respiratory tract mucosa and cause similar symptoms [22, 29, 31]. In addition, the result in our Wuhan cohort revealed that the self-reported symptoms of upper respiratory tract were not the first symptom in...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
